Literature DB >> 28004312

Quantitative measurements of myocardial perfusion and function from SPECT (and PET) studies depend on the method used to perform those measurements.

Guido Germano1,2.   

Abstract

Mesh:

Year:  2016        PMID: 28004312     DOI: 10.1007/s12350-016-0757-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  12 in total

1.  Automated quantification of myocardial perfusion SPECT using simplified normal limits.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

2.  The increasing role of quantification in clinical nuclear cardiology: the Emory approach.

Authors:  Ernest V Garcia; Tracy L Faber; C David Cooke; Russell D Folks; Ji Chen; Cesar Santana
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach.

Authors:  Guido Germano; Paul B Kavanagh; Piotr J Slomka; Serge D Van Kriekinge; Geoff Pollard; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

4.  Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes.

Authors:  Tali Sharir; Xingping Kang; Guido Germano; Jeroen J Bax; Leslee J Shaw; Heidi Gransar; Ishac Cohen; Sean W Hayes; John D Friedman; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

5.  "Same-Patient Processing" for multiple cardiac SPECT studies. 1. Improving LV segmentation accuracy.

Authors:  Guido Germano; Paul B Kavanagh; Mathews B Fish; Mark H Lemley; Yuan Xu; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2016-10-14       Impact factor: 5.952

6.  "Same-patient processing" for multiple cardiac SPECT studies. 2. Improving quantification repeatability.

Authors:  Guido Germano; Paul B Kavanagh; Terrence D Ruddy; R Glenn Wells; Yuan Xu; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2016-10-14       Impact factor: 5.952

7.  Myocardial perfusion and left ventricular quantitative parameters obtained using gated myocardial SPECT: Comparison of three software packages.

Authors:  Sotiria Alexiou; Panagiotis Georgoulias; George Angelidis; Varvara Valotassiou; Ioannis Tsougos; Dimitrios Psimadas; Velissarios Lakiotis; Agaristi Kaspiri; Dimitrios Alexopoulos; Dimitrios Apostolopoulos; Pavlos Vassilakos
Journal:  J Nucl Cardiol       Date:  2016-11-21       Impact factor: 5.952

Review 8.  Tracking a therapeutic response: how reliable are serial measurements of LV perfusion and function?

Authors:  Guido Germano; Paul B Kavanagh; Piotr J Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

9.  Automated quality control for segmentation of myocardial perfusion SPECT.

Authors:  Yuan Xu; Paul Kavanagh; Mathews Fish; James Gerlach; Amit Ramesh; Mark Lemley; Sean Hayes; Daniel S Berman; Guido Germano; Piotr J Slomka
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

10.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

View more
  2 in total

1.  The long way to dose reduction in myocardial perfusion imaging.

Authors:  Michela Lecchi; Angelo Del Sole
Journal:  J Nucl Cardiol       Date:  2017-06-30       Impact factor: 5.952

2.  New techniques, distinctive population, unique normal databases.

Authors:  James R Galt
Journal:  J Nucl Cardiol       Date:  2017-05-04       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.